Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • A ‘milestone’ moment: why economists think the global cycle of rate rises is over
    • OSCE in crisis as Russian veto threatens security body
    • Lawmakers warn that US is heading for shutdown as budget talks stall
    • Olaf Scholz accuses Poland of ‘waving through’ refugees as visa scandal deepens
    • Glenn Youngkin is not running for president. Or is he?
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Private equity firms pivot away from traditional buyouts
      • German fintech Solaris struggles to raise funds to execute major contract
      • Sale of THG boss’s business park falls through
      • Lego ditches oil-free brick in sustainability setback
      • EDF chief and French government clash over strategy
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Hedge funds rush to unwind bets against gilts
      • Jeremy Hunt plans Isa overhaul to boost share ownership
      • Singapore banks tighten scrutiny of clients after money-laundering scandal
      • German fintech Solaris struggles to raise funds to execute major contract
      • Russia dodges G7 price cap sanctions on most of its oil exports
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • A multi-speed Europe holds the key to EU enlargement
      • America’s mini economic miracle may be fleeting
      • Populism could derail the green transition
      • Russell Brand learnt his tricks in television studios
      • How to save your state pension
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • What Burberry taught me about the marketed mind
      • Paternity leave in finance: ‘The more men do it, the less of a big deal it becomes’
      • ‘There is no work to balance’: how shrinking budgets, Covid and AI shook up life in consulting
      • FT Business Books — what to read this month
      • Can I start a business when I have MS?
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Raffles London and the new era of super-luxe hospitality
      • Anna Wintour: ‘I just have to make sure things are being done right’
      • Who’d invite the boss to dinner?
      • The best museum gift shops in the world
      • 17 chefs share the side dishes they can’t do without
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Covid-19 vaccines

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 13 September, 2023
      Anjana Ahuja
      The rush to outpace Covid variants

      At least three descendants of Omicron have scientists on alert and vaccination programmes speeding up

      Andy Carter illustration of a man running away from coronavirus proteins while pushing a shopping trolley with a vaccine syringe in it
    • Monday, 11 September, 2023
      FDA approves new Covid-19 boosters from Pfizer and Moderna

      Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US

      A nurse fills a syringe with Covid-19 vaccine
    • Wednesday, 6 September, 2023
      Latest vaccines help tackle highly mutated new Covid variant

      Preliminary studies find exposure to prevalent XBB.1.5 strain elicits antibodies to BA.2.86

      A medical worker holds a syringe of the Moderna vaccine
    • Wednesday, 30 August, 2023
      England brings forward Covid booster vaccinations to counter new sub-variant

      Potential mutations prompts authorities to begin immunisation rollout in September

      A woman receives an injection
    • Wednesday, 30 August, 2023
      ExplainerCoronavirus
      ‘We haven’t seen the end of Covid’: surge in cases to test health systems

      As vaccines are tweaked while new sub-variants emerge, the virus cannot be treated yet as a seasonal bug

      Health workers wear face masks as they walk out of a government hospital in Chennai, India
    • Thursday, 17 August, 2023
      Jonathan Van-Tam takes role at vaccine maker Moderna

      Prominent figure in UK pandemic response becomes medical consultant at pharma group

      Sir Jonathan Van-Tam
    • Sunday, 6 August, 2023
      News in-depthResearch and development
      UK better prepared for next pandemic, say top scientists

      New vaccines centre supports aim to develop jab for any new potential killer pathogen within 100 days

      Scientists at the Vaccine Development and Evaluation Centre at Porton Down
    • Thursday, 20 July, 2023
      FT Magazine
      How a squad of MAGA warriors flush with cash turned on each other

      A doctor, a model and a boxer raised millions from Covid sceptics and anti-vaxxers. Then a knock-down, drag-out brawl broke out

    • Wednesday, 14 June, 2023
      FT MagazineGillian Tett
      The perils of open-source AI

      Experts are waking up to the threat posed by artificial intelligence programmes if they fall into malevolent hands

    • Sunday, 11 June, 2023
      BioNTech
      BioNTech faces hundreds of German compensation claims for Covid-19 jab

      Pharmaceuticals producer in first court hearing on Monday

      A patient receives the Pfizer/BioNTech vaccine in Leipzig, Germany
    • Friday, 26 May, 2023
      Brussels and Pfizer agree deal to cut supply of Covid vaccines

      Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes

      Woman receives Covid vaccination jab
    • Sunday, 14 May, 2023
      Novavax Inc
      Cash-strapped Novavax urges governments to honour Covid jab deals

      US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic

      Workers in a Novavax lab in Gaithersburg, Maryland
    • Friday, 12 May, 2023
      Simon Schama
      The thwarting of science will always be a human failing

      From India to Britain, we have always managed to get in the way of our own inventiveness

      Illustration of a hand being held up to say no to vaccines, and breaking an inoculation syringe in half
    • Tuesday, 9 May, 2023
      Janan Ganesh
      The west’s handling of the pandemic beat its own expectations

      A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules

      An elderly couple wearing face masks sit on a bench in Seville in May 2020, as Spain prepares to ease its tough lockdown measures
    • Monday, 1 May, 2023
      Noubar Afeyan
      Moderna co-founder calls on US politicians and judges to stop questioning science

      Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases

      Noubar Afeyan
    • Sunday, 30 April, 2023
      BioNTech/Pfizer’s mooted EU deal for 70mn Covid shots threatens rivals

      European health officials have advocated portfolio diversity to help fight different variants

      A teenager receives a Pfizer COVID-19 vaccine at a vaccination centre
    • Friday, 28 April, 2023
      Special ReportThe Americas’ Fastest Growing Companies
      Moderna tries to show it’s not a ‘one trick pony’

      Covid vaccine maker is sitting on $18bn and embarking on a host of ambitious projects

      A health worker prepares a dose of the Moderna COVID-19 vaccine
    • Wednesday, 26 April, 2023
      Pharmaceuticals sector
      EU aims to create ‘single market for medicines’ with overhaul of pharma rules

      Revamp that would cut drugmakers’ years of market exclusivity meets fierce opposition from sector

      Pharmacy worker opens a drawer full of drugs
    • Monday, 24 April, 2023
      EU business regulation
      EU outlines plan to take control of medicine production in health crises

      Proposal for compulsory licensing risks ire of pharma groups keen to protect patents and revenue

      A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production
    • Monday, 27 March, 2023
      BioNTech
      BioNTech forecasts slump in sales as demand for Covid jab wanes

      Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall

      A woman receives a booster dose of the BioNTech-Pfizer coronavirus vaccine
    • Wednesday, 15 March, 2023
      Taiwan
      Taiwan loses diplomatic ally as Honduras confirms link to China

      Central American nation was one of Taipei’s last partners in Washington’s backyard

      Honduras president Xiomara Castro
    • Tuesday, 14 March, 2023
      Pfizer’s revised EU Covid vaccine contract meets resistance

      Four member states including Poland say amended deal is not ‘fair solution’ to surplus of shots

      Lab worker with vials
    • Tuesday, 7 March, 2023
      UK spring Covid boosters will target elderly and vulnerable

      Health secretary confirms acceptance of advice from expert committee to ‘bridge the gap’ to autumn

      A vaccine against coronavirus is administered in England
    • Wednesday, 15 February, 2023
      CanSino says vaccine demand down after China’s mass Covid infections

      Pharma group hopes for approval of mRNA vaccine for booster shots

      A health worker gives a dose of CanSino’s inhalable Covid-19 vaccine in Bijie, Guizhou province, China
    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

      A scientist wearing rubber gloves working with test tubes and a microscope in a lab
    Previous page You are on page 1 Next page

    Recommended

    Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
    Covid vaccine development: The shots available and the doses administered
    In graphics: the UK vaccine supply chain
    Coronavirus: free to read
    Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
    Coronavirus tracker

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Global Pharma and Biotech Summit
    Driving life sciences innovation in a disrupted world
    Tuesday, 7 NovemberDigital Conference
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In